Skip to main content

Bad Blood

US scientists struggle to complete studies in Ecuador in the wake of biopiracy accusations.

Written byBeth Marie Mole
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

Waorani LeaderWIKIMEDIA, KATE FISHERAmerican biomedical researchers working in Ecuador have met with hostility and distrust in the aftermath of announcements last year that the country plans to sue researchers at Harvard University and the Coriell Institute for Medical Research over blood samples allegedly taken without the Ecuadorian government’s permission during the early 1990s. Representatives of the Waorani indigenous people claim that researchers collected cell lines and DNA samples under false pretenses and distributed them to scientific labs in other countries, which is in direct violation of Ecuador’s biopiracy laws. Public reports about the alleged genetic heist have riled Ecuadorians, which has led to a backlash for all researchers trying to do genetic and public health research in the South American country.

“We directly experienced suspicion,” said biological anthropologist Mark Sorensen of the University of North Carolina, who studies childhood disease in Ecuador. Though he was not involved in the controversial 90s study, last fall Sorensen called off a research project that involved collecting blood samples to evaluate biomarkers for inflammation. “We always try to be extra sensitive about [biopiracy] issues,” he says. “But government officials were reluctant to give approval.” The move forced Sorensen to hold-off his research and advise his graduate student to quickly switch her Ecuador-based dissertation work to another project in the nearby Galapagos Islands.

In statements last July, Ecuadorian Deputy Ombudsman Patricio Benalcazar explained his country’s outrage. Through research breakthroughs and future patents, he wrote, scientists could prosper from the genetic heritage ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays